<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">As we transition from our strict physical distancing guidelines to less stringent regulations and return to our clinical care activities, several uncertainties remain. Unfortunately SARS-CoV2 is a novel virus, and many deficiencies exist in the understanding of its behavior. These include 
 <italic>1)</italic> the exact case fatality rate is uncertain due to incomplete information on actual numbers of cases; 
 <italic>2)</italic> the timing of infectiousness relative to the onset of symptoms; 
 <italic>3)</italic> the large number of presymptomatic or asymptomatic infectious patients; 
 <italic>4)</italic> the duration of the infectious period; and 
 <italic>5)</italic> the accuracy of commercially available rapid diagnostic tests to determine whether a patient has COVID-19.
 <xref rid="bib9" ref-type="bibr">
  <sup>9</sup>
 </xref> Second, all surgical and nonsurgical procedures performed by oral-maxillofacial surgeons convey a high risk to HCP. Although some of these uncertainties and challenges will be resolved as the data regarding the virus and the disease improve, we all have some apprehension and reservations regarding delivering care in such an environment.
</p>
